CCEL Form 4 reports purchase transactions
PORTNOY DAVID reported open-market purchase transactions in a Form 4 filing for CCEL.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
PORTNOY DAVID reported open-market purchase transactions in a Form 4 filing for CCEL. The filing lists transactions totaling 5,826 shares at a weighted average price of $4.17 per share. Following the reported transactions, holdings were 122,838 shares.
Insider Trade Summary
Net Buyer: 5,826 shares
Net Buy
1 txn
Insider
PORTNOY DAVID
Role
Chairman, Co-CEO
Bought
5,826 shs ($24K)
Increase in Position
5.0%
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 5,826 | $4.1719 | $24K |
| Holding | Stock Option | -- | -- | -- |
| Holding | Stock Option | -- | -- | -- |
| Holding | Stock Option | -- | -- | -- |
| Holding | Stock Option | -- | -- | -- |
| Holding | Stock Option | -- | -- | -- |
| Holding | Stock Option | -- | -- | -- |
| Holding | Stock Option | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 122,838 shares (Indirect, By 401K);
Stock Option — 529,879 contracts (Direct);
Common Stock — 804,742 shares (Direct);
Common Stock — 230,621 shares (Indirect, By IRA);
Common Stock — 102,586 shares (Indirect, By Spouse);
Common Stock — 208,101 shares (Indirect, By Corporation);
Common Stock — 15,611 shares (Indirect, as Custodian for daughter);
Common Stock — 59,027 shares (Indirect, By LLC);
Common Stock — 33,377 shares (Indirect, As Custodian for son)
Holdings Before and After:
Common Stock, 117,012 to 122,838 shares (Indirect, By 401K)
Footnotes (6)
- F1. Stock options will vest immediately if the price of the Company's common stock reaches $25.00 per share during the seven-year option term.
- F2. 8,750 stock options vest upon issuance, 8,749 options vest on 1/2/2024, 21,000 options vest on 1/2/2025 and 11,501 options vest on 1/2/2026.
- F3. Stock options vest 1/3 upon issuance, 1/3 on December 22, 2024 and 1/3 on December 22, 2025.
- F4. Stock options vest 1/3 upon issuance, 1/3 on January 21, 2026 and 1/3 on January 21, 2027.
- F5. Shares of common stock held by Mayim Limited Partnership as is David Portnoy may be deemed the beneficial owner as the managing member and owner of Mayim Management, LLC, which is the general partner of Mayim Management Limited Partnership, which is the general partner of Mayim Investment Limited Partnership.
- F6. Shares of common stock held by uTIPu, Inc. as to which David Portnoy may be deemed the beneficial owner as the Chairman of the Board and Secretary.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did David Portnoy report for CCEL?
David Portnoy reported buying 5,826 CCEL shares. He purchased common stock on August 14, 2025, through a 401(k) account at a price of $4.1719 per share, increasing that account’s position to 122,838 shares of Cryo-Cell International.
What roles does David Portnoy hold at Cryo-Cell International (CCEL)?
David Portnoy is a director, Chairman, Co-CEO, and 10% owner. The filing identifies him as a member of the board, an executive officer serving as Chairman and Co-CEO, and a beneficial owner of more than ten percent of Cryo-Cell International’s common stock.
What stock option awards for CCEL does David Portnoy report holding?
Portnoy reports multiple CCEL stock option grants. The Form 4 lists options with exercise prices from $4.30 to $12.27 per share, covering amounts such as 280,000 and 50,000 shares, with expiration dates running from 2027 through 2030 and various vesting schedules.
AI-generated analysis. How Rhea-AI works. Not financial advice.
